India  

You Might Like

Vietnam to receive 1 million doses of AstraZeneca vaccine weekly from July


IndiaTimes - Published

AstraZeneca top expert backs India on widening Covishield dose gap


IndiaTimes - Published

When should you take second dose of Covishield vaccine? AstraZeneca says THIS

AstraZeneca on Friday backed the idea of keeping a 12-16 weeks gap between the two doses of the Covishield vaccine.
DNA - Published

AstraZeneca vaccine's chief investigator backs India's 12-16 week Covishield dose gap


IndiaTimes - Published

AstraZeneca and EU both claim win as court rules on vaccine supply row

astrazeneca and eu both claim win as court rules on vaccine supply row
AstraZeneca and the EU have both claimed victory in a court ruling over the supply of COVID-19 vaccines.
Sky News - Published

Covishield produces more antibodies than Covaxin, finds study

Covishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by Hyderabad-based Bharat Biotech in..
IndiaTimes - Published

US to ease Covid vaccine input supply: Kamala Harris to PM Modi

US Vice-President Kamala Harris on Thursday spoke to PM Narendra Modi to brief him about the Biden administration’s new vaccine policy that will clear supply chains for AstraZeneca and Novavax..
IndiaTimes - Published

Boris Johnson receives second dose of AstraZeneca COVID vaccine

Boris Johnson has had his second dose of the AstraZeneca COVID vaccine.
Sky News - Published

UK government negotiating with AstraZeneca to secure South African variant vaccine

uk government negotiating with astrazeneca to secure south african variant vaccine
The UK government has begun negotiations with AstraZeneca to secure a "variant vaccine" that can tackle the South African variant, Health Secretary Matt Hancock has said.
Sky News - Published

US redirects vaccine manufacturing supplies allowing India to make additional 20 million Covid vaccine doses

The US government on Friday redirected orders of critical vaccine manufacturing supplies, which will allow India to make over 20 million additional doses of AstraZeneca Covid-19 vaccines.
IndiaTimes - Published

ICMR to examine effectiveness of AstraZeneca's Covishield and Bharat Biotech's Covaxin


IndiaTimes - Published

Small number of people suffer stroke after AstraZeneca jab - as experts urge doctors to be alert

small number of people suffer stroke after astrazeneca jab - as experts urge doctors to be alert
Doctors have been told to look out for signs of stroke in patients who received the Oxford/AstraZeneca coronavirus jab after one person died and two others needed hospital treatment.
Sky News - Published

Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study

Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of Covid-19, first discovered in India, a new UK..
IndiaTimes - Published

'It would be a disaster': Vaccine hesitancy in some African nations risks jabs going out of date

'it would be a disaster': vaccine hesitancy in some african nations risks jabs going out of date
When the world-wide vaccine alliance, GAVI, announced that 132,000 AstraZeneca vaccines had been designated for South Sudan, doctors and health officials in this impoverished country were both..
Sky News - Published

3-month gap between doses improves immune response: AZ vax co-developer

A three-month gap between two doses of the AstraZeneca vaccine, known in India as Covishield, improves the immune response against Covid-19, according to Andrew Pollard, co-developer of the vaccine and..
IndiaTimes - Published

'Morally wrong' to offer COVID jabs to children while poorer nations suffer, says Oxford expert

'morally wrong' to offer covid jabs to children while poorer nations suffer, says oxford expert
It is "morally wrong" to offer coronavirus jabs to children in wealthy countries when people at greater risk in poorer nations remain unvaccinated, one of the scientists behind the Oxford-AstraZeneca..
Sky News - Published

Biggest AstraZeneca jab maker unlikely to resume exports 'for at least three months'

biggest astrazeneca jab maker unlikely to resume exports 'for at least three months'
The world's biggest maker of the AstraZeneca vaccine is unlikely to resume major exports until at least October as it prioritises doses for India's coronavirus crisis.
Sky News - Published

26 cases of blood clotting, bleeding due to AstraZeneca vaccine in India: Govt


IndiaTimes - Published

Under-40s to be offered alternative to Oxford jab over blood clot fears

All under-40s are to be offered an alternative to the Oxford/AstraZeneca coronavirus vaccine as a precaution.
Sky News - Published

US 'doing a lot for India' to meet Covid crisis: Joe Biden

President Joe Biden has said that the US was "doing a lot for India" by sending it oxygen and materials to make anti-Covid-19 vaccines. Biden's spokesperson Jen Psaki said that the US government was..
IndiaTimes - Published

Sweden plans to donate 1 million doses of AstraZeneca vaccines to India

Sweden plans to donate 1 million doses of AstraZeneca vaccines to India via the UN-backed COVAX, an initiative devised to give countries access to coronavirus vaccines regardless of their wealth.
IndiaTimes - Published

Serum Institute plans to start Covid vaccine production outside India: Report

The Serum Institute of India, which manufactures the AstraZeneca Covid-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief..
IndiaTimes - Published

5 million doses of COVID-19 vaccine Sputnik V in India by June, says Indian envoy to Russia Venkatesh Varma

New Delhi: India is set to get 5 million doses of Russian COVID vaccine Sputnik V by June, even as the vaccine is set to be rolled in the country from May 1. Sputnik V is the third vaccine India has..
DNA - Published